Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis. [electronic resource]
Producer: 20041216Description: 1670-2 p. digitalISSN:- 0003-4967
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antirheumatic Agents -- therapeutic use
- Cost of Illness
- Double-Blind Method
- Female
- Follow-Up Studies
- Germany
- Hospitalization -- statistics & numerical data
- Humans
- Infliximab
- Male
- Middle Aged
- Sick Leave -- statistics & numerical data
- Spondylitis, Ankylosing -- drug therapy
- Tumor Necrosis Factor-alpha -- antagonists & inhibitors
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.